|
Capzimin
|
化合物 T10672
|
2084868-04-0
|
|
EOAI3402143
|
1699750-95-2
|
1699750-95-2
|
|
USP30 inhibitor 11
|
(S)-1-cyano-N-(4-(6-cyano-5-methoxypyridin-2-yl)thiazol-2-yl)-N-methylpyrrolidine-2-carboxamide
|
2067332-64-1
|
|
FT671
|
化合物 T12621L
|
1959551-26-8
|
|
ML364
|
2-(4-甲基苯磺胺基)-N-(4-苯基噻唑-2-基)-4-三氟甲基苯甲酰胺
|
1991986-30-1
|
|
BVT 2733
|
BVT 2733
|
376640-41-4
|
|
AG-120
|
艾伏尼布
|
1448347-49-6
|
|
6-Aminonicotinamide
|
6-氨基煙酰胺
|
329-89-5
|
|
NCT-503
|
NCT503
|
1916571-90-8
|
|
Methylmalonate
|
甲基丙二酸
|
516-05-2
|
|
Alda 1
|
N-(1,3-苯并二氧雜環(huán)戊烯-5-基甲基)-2,6-二氯苯甲酰胺
|
349438-38-6
|
|
CBR-5884
|
CBR-5884
|
681159-27-3
|
|
PluriSIn #1 (NSC 14613)
|
NSC 14613
|
91396-88-2
|
|
Trilostane
|
亞硝酸鹽環(huán)氧雄烷
|
13647-35-3
|
|
Gimeracil
|
吉莫斯特
|
103766-25-2
|
|
DL-α-Hydroxyglutaric acid disodium salt
|
DL-Α-羥基戊二酸二鈉
|
40951-21-1
|
|
L-a-Hydroxyglutaric acid disodium salt
|
S-2-羥基戊二酸
|
63512-50-5
|
|
DDR Inhibitor
|
1644069-80-6
|
1644069-80-6
|
|
7rh
|
DDR1-IN-2
|
1429617-90-2
|
|
DDR1-IN-5
|
DDR1-IN-5
|
2416022-90-5
|
|
WRG-28
|
WRG-28
|
1913291-02-7
|
|
Triptonide
|
雷公藤內酯酮
|
38647-11-9
|
|
Pentoxyresorufin
|
7-(戊氧基)-3H-吩惡嗪-3-酮
|
87687-03-4
|
|
Cobicistat (GS-9350)
|
可比司他
|
1004316-88-4
|
|
PF-06928215
|
PF-06928215
|
2378173-15-8
|
|
RU.521
|
RU320521
|
2262452-06-0
|
|
Cyanine3 carboxylic acid
|
Cyanine3 羧酸
|
1032678-01-5
|
|
Cy7 NHS ester (non-sulfonated)
|
CYCLOHEXANE CYANINE7 NHS
|
1432019-64-1
|
|
Cyanine 7 amine
|
Cy7-伯胺
|
1650559-73-1
|
|
MF-094
|
化合物MF-094
|
2241025-68-1
|
|
USP7-IN-3
|
USP7-IN-3
|
2202738-42-7
|
|
GNE-6640
|
CS-2824
|
2009273-67-8
|
|
GRL0617
|
5-Amino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide
|
1093070-16-6
|
|
IU1-47
|
IU1-47
|
670270-31-2
|
|
Fresolimumab
|
非蘇木單抗
|
948564-73-6
|
|
Sabatolimab
|
SABATOLIMAB
|
2252262-24-9
|
|
Adalimumab
|
阿達木單抗
|
331731-18-1
|
|
Vedolizumab
|
維多珠單抗
|
943609-66-3
|
|
Tocilizumab
|
托珠單抗
|
375823-41-9
|
|
Caplacizumab
|
卡拉西單抗
|
915810-67-2
|
|
Benralizumab
|
BENRALIZUMAB
|
1044511-01-4
|
|
Dupilumab
|
度匹魯單抗
|
1190264-60-8
|
|
Tesnatilimab
|
特拉佐利單抗
|
2242758-08-1
|
|
Tiragolumab
|
替瑞利尤單抗
|
1918185-84-8
|
|
Tiopinac
|
硫平酸
|
61220-69-7
|
|
Parcetasal
|
MR 897
|
87549-36-8
|
|
PPA-904
|
PPA-904
|
30189-85-6
|
|
Deprodone propionate
|
丙酸地潑羅酮
|
20424-00-4
|
|
TGN-020
|
TGN-020
|
51987-99-6
|
|
3-Acetamidocoumarin
|
3-乙酰氨基香豆素
|
779-30-6
|
|
G6PDi-1
|
4-((5-氧代-6,7,8,9-四氫-5H-環(huán)庚并[D]嘧啶-2-基)氨基)噻吩-2-甲腈
|
2457232-14-1
|
|
Dimethyl sulfoxide
|
二甲基亞砜
|
67-68-5
|
|
Vudalimab
|
VUDALIMAB
|
2329669-72-7
|
|
BC-1471
|
化合物 T8553
|
896683-84-4
|
|
K6PC-5
|
K6PC-5
|
756875-51-1
|
|
IPN60090 dihydrochloride
|
IPN60090 DIHYDROCHLORIDE
|
2102101-72-2
|
|
ZED-1227
|
ZED-1227
|
1542132-88-6
|
|
SM-276001
|
SM-276001
|
473930-22-2
|
|
Cletoquine oxalate
|
氯托喹草酸
|
14142-64-4
|
|
Abatacept
|
Unii-7D0yb67S97
|
332348-12-6
|
|
Ipilimumab
|
伊匹單抗
|
477202-00-9
|
|
MSX-127
|
NSC-23026
|
6616-56-4
|
|
CXCR7 modulator 1
|
CXCR7 modulator 1
|
2231812-31-8
|
|
NUCC-390 dihydrochloride
|
化合物 NUCC-390 DIHYDROCHLORIDE
|
2749281-71-6
|
|
USL311
|
USL311
|
1373268-67-7
|
|
CXCR2-IN-2
|
CXCR2-IN-2
|
1838123-21-9
|
|
ML339
|
化合物ML339
|
2579689-83-9
|
|
CXCR2 antagonist 2
|
化合物 CXCR2 ANTAGONIST 2
|
2647464-91-1
|
|
ACT-1004-1239
|
ACT-1004-1239
|
2178049-58-4
|
|
CXCR2 antagonist 8
|
化合物 CXCR2 ANTAGONIST 8
|
182498-30-2
|
|
ACT-660602
|
化合物 ACT-660602
|
1646267-59-5
|
|
Elubrixin tosylate
|
ELUBRIXIN TOSYLATE
|
960495-43-6
|
|
Ladarixin sodium
|
865625-56-5
|
865625-56-5
|
|
LY2510924
|
CS-2675
|
1088715-84-7
|
|
AZD-5069
|
AZD5069
|
878385-84-3
|
|
Cyanine5 carboxylic acid
|
Cy5 羧酸
|
1032678-07-1
|
|
Cyanine 5.5 maleimide
|
Cy5.5-馬來酰亞胺
|
1593644-50-8
|
|
Cy5-NHS ester
|
Cy5-NHS 活化酯
|
1032678-42-4
|
|
Cyanine 5 amine
|
Cy5-伯胺
|
1807529-70-9
|
|
Cyanine5 maleimide
|
Cy5-馬來酰亞胺
|
1437796-65-0
|
|
Cyanine 7.5 NHS ester
|
Cy7.5-NHS 活化酯
|
786620-92-6
|
|
Cyanine 7 NHS Ester
|
Cy7-NHS 活化酯
|
1432466-81-3
|
|
Cyanine3 maleimide
|
Cy3-馬來酰亞胺
|
1593644-29-1
|
|
NBI-74330
|
N-[(1R)-1-[3-(4-乙氧基苯基)-3,4-二氫-4-氧代吡啶并[2,3-D]嘧啶-2-基]乙基]-4-氟-N-(3-吡啶基甲基)-3-(三氟甲基)苯乙酰胺
|
855527-92-3
|
|
CXCR2-IN-1
|
1873376-49-8
|
1873376-49-8
|
|
(R,R)-CXCR2-IN-2
|
(R,R)-CXCR2-IN-2
|
1838123-22-0
|
|
CXCR7 antagonist-1
|
CXCR7拮抗劑1
|
1613021-99-0
|
|
Vimnerixin
|
N-(6-(((2R,3S)-3,4-dihydroxybutan-2-yl)oxy)-2-((4-fluorobenzyl)thio)pyrimidin-4-yl)-3-methylazetidine-1-sulfonamide
|
1418112-77-2
|
|
TAK-779
|
TAK 799 ;TAK 779
|
229005-80-5
|
|
Kynurenic acid sodium
|
Kynurenic acid sodium salt
|
2439-02-3
|
|
AMD-070
|
N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氫喹啉-8-基)丁烷-1,4-二胺
|
558447-26-0
|
|
Reparixin
|
REPERTAXIN
|
266359-83-5
|
|
BKT140
|
BKT140
|
664334-36-5
|
|
SCH 527123
|
3-[[3-[(二甲基氨基)羰基]-2-羥基苯基]氨基]-4-[[(R)-1-(5-甲基呋喃-2-基)丙基]氨基]-3-環(huán)丁烯-1,2-二酮
|
473727-83-2
|
|
AMD-070 trihydrochloride
|
N-(1H-苯并咪唑-2-基甲基)-N-[(8S)-5,6,7,8-四氫-8-喹啉基]-1,4-丁二胺單鹽酸鹽
|
880549-30-4
|
|
(2,5-Dioxopyrrolidin-1-yl) 6-[2-[(E,3Z)-3-(3-ethyl-1,3-benzoxazol-2-ylidene)prop-1-enyl]-1,3-benzoxazol-3-ium-3-yl]hexanoate;iodide
|
Cy2-NHS活化酯
|
186205-33-4
|
|
Cyanine3.5 NHS ester
|
Cy3.5-NHS 活化酯
|
2231670-85-0
|
|
Cyanine 3.5 carboxylic acid
|
Cy3.5羧酸
|
1144107-79-8
|
|
Cyanine3 NHS Ester
|
Cy3-NHS 活化酯
|
1032678-38-8
|
|
Cy3 amine
|
Cy3-伯胺
|
2247688-56-6
|